BRIEF-Newamsterdam Pharma Announces Positive Alzheimer’S Disease Data From Broadway Clinical Trial
Reuters
Jun 09
BRIEF-Newamsterdam Pharma Announces Positive Alzheimer’S Disease Data From Broadway Clinical Trial
June 9 (Reuters) - NewAmsterdam Pharma Company NV KH6.F:
NEWAMSTERDAM PHARMA ANNOUNCES POSITIVE TOPLINE ALZHEIMER’S DISEASE DATA FROM BROADWAY CLINICAL TRIAL
NEWAMSTERDAM PHARMA COMPANY NV - OBICETRAPIB SHOWS SIGNIFICANT REDUCTIONS IN ALZHEIMER'S BIOMARKER
Source text: ID:nGNX9g2d0X
Further company coverage: KH6.F
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.